Gyno-Pevaryl (Econazole Nitrate)

Gyno-Pevaryl is indicated for the treatment of several superficial fungal infections affecting the skin and vaginal mucosa.

• Vulvovaginal candidiasis (yeast infection of the vagina and vulva)
• Cutaneous candidiasis, including intertriginous and moist skin areas
• Dermatophyte infections such as tinea corporis, tinea cruris, and tinea pedis
• Prevention of recurrent fungal infections following successful therapy
• Adjunctive therapy for mixed bacterial‑fungal infections when directed by a clinician

The safety profile of Gyno-Pevaryl reflects the typical adverse reactions seen with topical imidazole antifungals.

Common

• Local itching or pruritus at the application site
• Burning or stinging sensation during or after use
• Mild redness or erythema of the skin or vaginal mucosa
• Slight irritation or discomfort that resolves with continued use
• Vaginal discharge that is thin and non‑purulent

Serious

• Acute allergic reaction such as urticaria or angio‑edema
• Severe contact dermatitis with extensive swelling or blistering
• Respiratory difficulty or wheezing indicating systemic hypersensitivity
• Systemic signs such as fever, chills, or malaise (rare)
• Signs of toxicity including nausea, headache, or dizziness (uncommon)

Before using Gyno-Pevaryl, certain precautions should be considered to minimize risks and ensure appropriate therapy.

• Confirm diagnosis of fungal infection; avoid use for bacterial or viral conditions without medical advice
• Do not apply to broken, inflamed, or ulcerated skin unless directed by a clinician
• Use only for the prescribed duration; prolonged use may increase resistance
• Pregnant or breastfeeding individuals should discuss potential risks with a healthcare provider
• Patients with known hypersensitivity to econazole or other imidazoles should avoid the product
• Keep the medication out of reach of children and store according to label instructions

Gyno-Pevaryl may interact with other topical agents or systemic medications that affect fungal metabolism or skin integrity.

Avoid

• Concurrent use of other topical antifungal or corticosteroid preparations at the same site without professional guidance
• Systemic azole antifungals (e.g., fluconazole, itraconazole) that could increase local drug concentration

Use with caution

• Products containing alcohol, astringents, or harsh surfactants that may irritate the mucosa
• Vaginal douches, spermicides, or lubricants that could alter drug absorption
• Immunosuppressive therapy that predisposes to opportunistic infections
• Dermatologic agents that cause photosensitivity when combined with sun exposure